Product NDC: | 59762-0104 |
Proprietary Name: | Sulfasalazine |
Non Proprietary Name: | SULFASALAZINE |
Active Ingredient(s): | 500 mg/1 & nbsp; SULFASALAZINE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59762-0104 |
Labeler Name: | Greenstone LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA007073 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20050505 |
Package NDC: | 59762-0104-2 |
Package Description: | 300 TABLET, DELAYED RELEASE in 1 BOTTLE (59762-0104-2) |
NDC Code | 59762-0104-2 |
Proprietary Name | Sulfasalazine |
Package Description | 300 TABLET, DELAYED RELEASE in 1 BOTTLE (59762-0104-2) |
Product NDC | 59762-0104 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SULFASALAZINE |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20050505 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Greenstone LLC |
Substance Name | SULFASALAZINE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |